SPDR S&P Pharmaceuticals ETF: (XPH)
(Delayed Data from NYSE) As of May 17, 2024 03:54 PM ET
$41.19 USD
-0.09 (-0.22%)
Volume: 11,182
After-Market: $41.07 -0.12 (-0.29 %) 7:58 PM ET
ETF Quote Details
Previous Close | 41.28 |
Open | 41.27 |
Bid | 40.82 |
Ask | 41.56 |
Day Low-High | 41.06-41.27 |
52wk Low-High | 34.67-45.62 |
Volume | 11,182 |
NAV (month end) | 39.80 |
Premium (+)/Discount (-) (month end) | +1.48 |
ETF Expense Ratio
Expense Ratio | 0.35% |
Dividend (Yield) | $0.59 (1.44%) |
Issuer | STATE STREET GLOBAL ADVISORS |
Benchmark for XPH
SP PHARMACEUTICALS SELECT INDUSTRY INDEX
The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.
Fund Summary for XPH
SPDR S&P PHARMACEUTICALS ETF
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.